OtherArticle
Cyclic conversion of the Novel SRC Kinase Inhibitor TG100435 and its N-oxide metabolite by Flavin-containing Monoxygenases and Cytochromes P450 Reductase
Ahmed A Kousba, Richard M Soll, Shiyin Yee and Michael B Martin
Drug Metabolism and Disposition September 19, 2007, DOI: https://doi.org/10.1124/dmd.107.017384
Ahmed A Kousba
Richard M Soll
Shiyin Yee
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherArticle
Cyclic conversion of the Novel SRC Kinase Inhibitor TG100435 and its N-oxide metabolite by Flavin-containing Monoxygenases and Cytochromes P450 Reductase
Ahmed A Kousba, Richard M Soll, Shiyin Yee and Michael B Martin
Drug Metabolism and Disposition September 19, 2007, DOI: https://doi.org/10.1124/dmd.107.017384
OtherArticle
Cyclic conversion of the Novel SRC Kinase Inhibitor TG100435 and its N-oxide metabolite by Flavin-containing Monoxygenases and Cytochromes P450 Reductase
Ahmed A Kousba, Richard M Soll, Shiyin Yee and Michael B Martin
Drug Metabolism and Disposition September 19, 2007, DOI: https://doi.org/10.1124/dmd.107.017384
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement